AMDL gets export clearance for DR-70:
This article was originally published in Clinica
Executive Summary
The US FDA has given AMDL permission to export its lung cancer test, DR-70, to Canada. Canadian marketing clearance was granted earlier this month (see Clinica No 669/70, p 30). Briana Biotech is expecting to begin selling the kit sometime in the fourth quarter. AMDL says International Cancer Diagnostics, the joint marketing venture it formed with Briana in February, is holding preliminary discussions with a number of overseas diagnostics companies.